Report on webinar series cell and gene therapy: from concept to clinical use

Christopher F. van der Walle, Christine Dufès, Arpan S. Desai, Julie Kerby, Joanne Broadhead, Alice Tam, Zahra Rattray

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Abstract

With the launch of the UK Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products Focus Group in late 2020, a webinar series reviewing the current and emerging trends in cell and gene therapy was held virtually in May 2021. This webinar series was timely given the recent withdrawal of the United Kingdom from the European Union and the global COVID-19 pandemic impacting all sectors of the pharmaceutical sciences research landscape globally and in the UK. Delegates from the academic, industry, regulatory and NHS sectors attended the session where challenges and opportunities in the development and clinical implementation of cell and gene therapies were discussed. Globally, the cell and gene therapy market has reached a value of 4.3 billion dollars in 2020, having increased at a compound annual growth rate of 25.5% since 2015. This webinar series captured all the major developments in this rapidly-evolving area and highlighted emerging concepts warranting cross-sector efforts from across the community in the future.
Original languageEnglish
Article number168
Number of pages10
JournalPharmaceutics
Volume14
Issue number1
Early online date11 Jan 2022
DOIs
Publication statusPublished - 11 Jan 2022

Keywords

  • cell therapy
  • gene therapy
  • similars
  • manufacture
  • in vivo gene therapy
  • viral vectors

Fingerprint

Dive into the research topics of 'Report on webinar series cell and gene therapy: from concept to clinical use'. Together they form a unique fingerprint.

Cite this